http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#Head http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#assertion http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#provenance http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#pubinfo http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#assertion http://purl.obolibrary.org/obo/DOID_8567 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_8567 http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00997 http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association http://www.w3.org/2000/01/rdf-schema#label doxorubicin hydrochloride hcl for injection is an anthracycline topoisomerase ii inhibitor indicated as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer 1 1 for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non hodgkin lymphoma metastatic breast cancer metastatic wilms tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcomas metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma 1 2 doxorubicin hcl for injection is indicated as a component of multi agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer see clinical studies 14 doxorubicin hcl for injection is indicated for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non hodgkin lymphoma nhl metastatic breast cancer metastatic wilms tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00997 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#provenance http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#pubinfo http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#sig http://purl.org/nanopub/x/hasSignature LEIQ/cpdohSQ5m9E2Q/TKUp307x+mcc1aHt5puaGwwU+A0VEWfcc0vjLLEY2YLNCbhcTkabN1Q2WbCg8WxYiuS88gB8A1yNLa6wRizZ+p2gFvOtctC/Jd8Ptywu+IwEAeWa2DF36uo/N41eClvMsSreWpQKsIlb7jKmtCn4w9MY= http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://purl.org/dc/terms/created 2021-06-13T12:12:48.292+02:00 http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAkE3bPS-i7W0lxPLkxXAmALTFty4a9zrg1RmAVzSbV9c https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs